Compare NTSK & ATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTSK | ATR |
|---|---|---|
| Founded | 2012 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Plastic Products |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6B | 9.3B |
| IPO Year | 2025 | 1993 |
| Metric | NTSK | ATR |
|---|---|---|
| Price | $22.90 | $115.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 4 |
| Target Price | $26.85 | ★ $167.50 |
| AVG Volume (30 Days) | ★ 2.0M | 557.9K |
| Earning Date | 12-11-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 1.66% |
| EPS Growth | N/A | ★ 24.99 |
| EPS | N/A | ★ 6.23 |
| Revenue | $615,512,000.00 | ★ $3,662,533,000.00 |
| Revenue This Year | $28.34 | $3.99 |
| Revenue Next Year | $23.46 | $3.38 |
| P/E Ratio | ★ N/A | $18.58 |
| Revenue Growth | ★ 32.29 | 2.50 |
| 52 Week Low | $17.32 | $103.23 |
| 52 Week High | $27.99 | $174.10 |
| Indicator | NTSK | ATR |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 32.60 |
| Support Level | N/A | $120.80 |
| Resistance Level | N/A | $124.26 |
| Average True Range (ATR) | 0.00 | 2.56 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 0.00 | 3.64 |
Netskope Inc is redefining the security and networking of cloud and AI. The company has formed a cloud-native platform that offers converged security and networking services to enable fast and secure AI, cloud, and web access at the edge.
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (49% of sales) and the United States (32%), Aptar aims to increase its presence in Asia (11%) and Latin America (8%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.